PharmaTimes The company noted a 31% decline in the antipsychotic Seroquel (quetiapine) franchise to $438 million, while sales of the antihypertensive Atacand ( candesartan ) sank 37% to $166 million. In oncology, Arimidex (anastrozole) fell 39% to $83 million and ... and more »
GenomeWeb Launched in 1996, ABCSG8 compared the efficacy and safety of tamoxifen as a single agent versus tamoxifen followed by anastrozole in post-menopausal, hormone receptor-positive early-stage breast cancer patients (PGx Reporter 5/16/2012).
